Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

219 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-World Efficacy and Safety of Durvalumab Administration Following Chemoradiotherapy in Elderly Patients With Unresectable Locally Advanced Nonsmall Cell Lung Cancer: A Multicenter, Retrospective Study.
Kakiuchi Y, Saruwatari K, Murotani K, Tokito T, Iriki T, Iwakawa J, Sakata Y, Shingu N, Saeki S, Inaba M, Takaki A, Misono S, Suetsugu T, Azuma K, Mizuno K, Sakagami T. Kakiuchi Y, et al. Clin Lung Cancer. 2024 Dec;25(8):661-671.e7. doi: 10.1016/j.cllc.2024.07.001. Epub 2024 Jul 6. Clin Lung Cancer. 2024. PMID: 39095234
Clinical outcomes and predictive value of programmed cell death-ligand 1 expression in response to anti-programmed cell death 1/ligand 1 antibodies in non-small cell lung cancer patients with performance status 2 or greater.
Jodai T, Saruwatari K, Ikeda T, Moriyama E, Kashiwabara K, Shingu N, Iyonaga K, Inaba M, Ajishi Y, Honda C, Hirosako S, Maruyama H, Kakiuchi Y, Eida H, Tomita Y, Saeki S, Ichiyasu H, Sakagami T. Jodai T, et al. Among authors: kakiuchi y. Int J Clin Oncol. 2021 Jan;26(1):78-86. doi: 10.1007/s10147-020-01789-5. Epub 2020 Sep 23. Int J Clin Oncol. 2021. PMID: 32965577
Acute coronary syndrome as a possible immune-related adverse event in a lung cancer patient achieving a complete response to anti-PD-1 immune checkpoint antibody.
Tomita Y, Sueta D, Kakiuchi Y, Saeki S, Saruwatari K, Sakata S, Jodai T, Migiyama Y, Akaike K, Hirosako S, Fujisue K, Yamamura S, Miyazaki S, Takashio S, Izumiya Y, Nakamura K, Tsujita K, Ichiyasu H, Fujii K. Tomita Y, et al. Among authors: kakiuchi y. Ann Oncol. 2017 Nov 1;28(11):2893-2895. doi: 10.1093/annonc/mdx326. Ann Oncol. 2017. PMID: 28651328 Free article. No abstract available.
Predictive marker for response to trifluridine/tipiracil plus bevacizumab in metastatic colorectal cancer patients.
Takahashi T, Shigeyasu K, Kondo Y, Takeda S, Umeda H, Moriwake K, Kayano M, Sakurai Y, Nakamura S, Takahashi M, Nitta K, Yoshida K, Matsumi Y, Michiue H, Yamamoto H, Kishimoto H, Teraishi F, Shoji R, Kanaya N, Kashima H, Kakiuchi Y, Kuroda S, Kagawa S, Fujiwara T. Takahashi T, et al. Among authors: kakiuchi y. BMC Cancer. 2025 Jan 2;25(1):1. doi: 10.1186/s12885-024-13370-8. BMC Cancer. 2025. PMID: 39748254 Free PMC article.
219 results